- This topic is empty.
-
Posts
-
Understanding Dapagliflozin and Its Place in Synthetic Chemistry Research
Dapagliflozin belongs to the SGLT2 inhibitor class of chemical structures, a molecular grouping frequently explored alongside DPP-4 inhibitor and oral GLP-1 receptor agonist frameworks within the landscape of complex heterocyclic building blocks. For chemistry research teams, custom synthesis labs and contract manufacturing partners sourcing Dapagliflozin-related intermediates, the procurement decision is rarely focused on a single compound alone. The core priority is finding a supplier capable of consistent delivery across the full synthetic sequence, paired with traceable testing records and robust quality workflows that support reproducible lab and scale-up work.
This guide covers practical evaluation criteria for teams selecting a Dapagliflozin intermediate supplier, referencing the product portfolio and operational setup of Shandong Tianming Pharmaceutical Group, operating commercially as Tianming Pharmaceutical.
Mapping the Dapagliflozin Synthetic Route Portfolio
Before comparing suppliers, sourcing teams need clarity on which stage of the synthetic pathway fits their project needs. Tianming Pharmaceutical’s library of complex heterocyclic compounds includes a sequential set of building blocks applied in Dapagliflozin synthetic studies:
- 2-Chloro-5-bromobenzoic acid (CAS 217399-2-4)
- (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone (CAS 461432-21-4)
- 5-Bromo-2-chloro-4′-ethoxydiphenylmethane (CAS 461432-23-5)
- Tetraacetyl Dapagliflozin (CAS 461432-25-7)
- Dapagliflozin Monohydrate Propylene Glycol (CAS 960404-48-2)
This continuous synthetic sequence brings tangible advantages for research programs. A common industry challenge arises when different steps of one route are sourced from multiple vendors: fragmented procurement pushes up coordination costs and increases the risk of mismatched process parameters. Teams that source only one isolated intermediate often face setbacks when a separate supplier cannot replicate the required purity profile or agreed lead time for the next synthetic step.
Key Factors to Evaluate When Buying Dapagliflozin Intermediates
Quality Assurance and Documentation
Reliable suppliers maintain structured quality management frameworks and relevant third-party certifications. Tianming Pharmaceutical’s manufacturing affiliates hold ISO9001 Quality Management System Certification: Shandong Sihuan Pharmaceutical Co., Ltd. (2025) and Guangxi Tianming Pharmaceutical Co., Ltd. (2024). Full batch traceability is equally critical: incoming raw material logs, reaction parameters, purification records and analytical test data are archived to maintain a complete chain of custody. COA and structural confirmation documentation are available for every shipped batch.
Production Scale and Supply Reliability
Scalability is essential when projects progress from small laboratory batches to larger synthesis campaigns. Tianming Pharmaceutical runs three coordinated production sites: Shandong Sihuan Pharmaceutical Co., Ltd. in Dezhou, Jining Tianming Pharmaceutical Co., Ltd. in Jining, and Guangxi Tianming Pharmaceutical Co., Ltd. in Hechi. Combined, the facilities host more than 160 reactor vessels, supporting annual output capacity at the hundred-ton scale. This multi-site layout lowers supply disruption risks and supports customers scaling from pilot batches to ton-volume synthesis runs.
R&D and Technical Support
A supplier’s in-house chemistry expertise determines its ability to troubleshoot process challenges and refine impurity control methods. Tianming Pharmaceutical operates two R&D centers in Jinan and Nanjing, with over 6,000 square meters of laboratory space and an R&D team of more than 100 specialists. The group has invested over RMB 40 million in analytical and process equipment, including HPLC, gas chromatography, mass spectrometry, LC-MS and chiral analysis instrumentation, managed under an integrated product development workflow. Annual R&D investment exceeds 10% of revenue, above the roughly 5% industry average cited by the company.
Delivery, Logistics, and After-Sales Service
Timeline reliability is often decisive for teams working against internal project milestones. In-stock materials are processed for shipment within 7–15 working days, covering order confirmation, quality review, packaging and dispatch. Lead times for custom synthesis depend on synthetic complexity, workshop scheduling and raw material availability; expedited arrangements can be arranged for time-sensitive research projects. For international shipments, the company supports air freight, sea freight and express courier options. Temperature-controlled handling is available for heat-sensitive substances, alongside nitrogen-filled vacuum packaging for materials prone to oxidation. All shipments are covered by transport insurance, with replacement or compensation arrangements for quality damage incurred in transit.
On the service side, each customer is assigned a dedicated account manager paired with a technical engineer for dual support. Routine technical inquiries receive supporting reference data within 2 hours, while complex technical matters are summarised in a formal written report within 24 hours. Scheduled follow-up communication is maintained, and on-site technical consultation can be arranged for bulk and framework cooperation clients.
Why One-Stop Sourcing Reduces Procurement Risk
A core feature of Tianming Pharmaceutical’s offering is integrated one-stop supply, covering gram-scale lab samples, pilot scale-up and large-batch synthesis under a single supplier relationship. This service comes with comprehensive technical documentation packages, including COA, analytical methods (MOA), impurity profile datasets and stability test records, built to support customers’ internal analytical validation and process development work. For teams working with Dapagliflozin intermediates, consolidating sourcing with a supplier that provides this full set of technical records streamlines internal data collation, compared with compiling information separately from multiple vendors.
Evaluating Supplier Credibility
Technical specifications should always be paired with background due diligence. Shandong Tianming Pharmaceutical Group was formally established in 2020, built upon its predecessor Shandong Sihuan Pharmaceutical Co., Ltd., founded in 2010, with headquarters in Jinan, Shandong Province. The group is recognised as a National High-Tech Enterprise. Its subsidiaries in Shandong and Guangxi have obtained provincial Gazelle Enterprise and Specialized and Innovative SME accreditations. It serves more than 2,000 collaborative clients domestically and internationally, with business reach across over 30 countries and regions in South Asia, Southeast Asia, the Middle East, Central and South America, and Africa, backed by local overseas business entities in India and Bangladesh.
A Practical Checklist for Buyers
Before finalising a purchase of Dapagliflozin intermediates, confirm the following points:
- The exact intermediate or synthetic stage (starting material, advanced intermediate) required, cross-referenced with corresponding CAS numbers
- Availability of complete supporting documents, including COA, structural verification data and batch traceability records for internal analytical work
- Available production capacity and whether multi-site manufacturing reduces single-source supply risks
- Lead times for stocked items and custom synthesis orders, plus international logistics options
- Scope of technical and after-sales support, including response SLAs for process and quality enquiries
Conclusion
Sourcing Dapagliflozin intermediates requires careful assessment of supply chain stability and documentation quality, alongside synthetic performance. Buyers who assess partners based on quality systems, scalable production, R&D capability and responsive technical support — rather than price alone — are better positioned to avoid delays and inconsistent material quality that commonly complicate chemical procurement. Tianming Pharmaceutical’s certified quality management framework, multi-site production footprint and unified supply model spanning gram to ton volumes make it a viable reference partner for chemistry teams and custom synthesis providers searching for Dapagliflozin intermediate supply.
Disclaimer: All compounds are offered solely for laboratory research and process development purposes. Not for therapeutic use, clinical application or human administration.
Tianming Pharmaceutical Group
- You must be logged in to reply to this topic.